The antitumor activity of the platinum complex D-17872 is associated with tumor cell differentiation.

Abstract

The novel cisplatin analogue D-17872 was studied for its anticancer activity using in vivo and in vitro preclinical models. The compound at the sublethal dose of 215 mg/kg (ca. 50% of the approximate LD50) induced no nephrotoxic effect strong enough to increase the blood urea level in rats. It had good in vivo antitumor efficacy against murine P388 (max. ILS: D-17872 132%, cisplatin 55%) and L1210 leukemia (max. ILS: D-17872 43%, cisplatin 38%), L5222 leukemia of the rat (max. ILS: D-17872 163%, cisplatin 163%) and murine B16 melanoma. Activity against P388 leukemia substantially exceeded that of cisplatin. Moreover, the M5076 reticulum cell sarcoma implanted into the subrenal capsule and the DMBA-induced mammary tumor of the rat were inhibited by D-17872 to a greater extent than by cisplatin (min. T/C: D-17872 -3%, cisplatin 11%). Using clonogenic microassays, D-17872 was active in vitro against a variety of human and rodent tumor cell lines, albeit at higher concentrations than cisplatin (IC50 values: D-17872 2.6-12.7 mumol/l, cisplatin 0.13-0.42 mumol/l). Apart from its cytotoxic action it was able to induce in vitro differentiation of the human HL-60 and K562 and of the murine M1-T22 cell lines, while cisplatin induced differentiation only in the HL-60 cell line. Thus D-17872 exhibited a pharmacological and toxicological profile different from that of the parent compound. The results suggest that induction of differentiation contributes to the antineoplastic efficacy of this novel cisplatin derivative.

• Authors: H R Maurer, C Echarti, R Voegeli, J Pohl, P Hilgard
• Journal: Cancer chemotherapy and pharmacology (Cancer Chemother Pharmacol) Vol. 32 Issue 2 Pg. 123-8 ( 1993) ISSN: 0344-5704 [Print] Germany
• PMID: 8485806 (Publication Type: Journal Article)

Chemical References

• Antineoplastic Agents
• Ethylenediamines
• D 17872
• Cisplatin

Topics

• Animals
• Antineoplastic Agents (pharmacology, therapeutic use)
• Cell Differentiation (drug effects)
• Cell Division (drug effects)
• Cisplatin (administration & dosage, analogs & derivatives, pharmacology, therapeutic use)
• Erythrocytes (drug effects)
• Ethylenediamines (administration & dosage, pharmacology, therapeutic use)
• Female
• Injections, Intraperitoneal
• Male
• Mice
• Mice, Inbred C57BL
• Monocytes (drug effects)
• Neoplasms, Experimental (drug therapy, pathology)
• Rats
• Rats, Sprague-Dawley
• Tumor Cells, Cultured